AIM
ZBH icon

Achmea Investment Management’s Zimmer Biomet ZBH Stock Holding History

Achmea Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-27,030
Closed -$2.93M – 445
2024
Q2 		$2.93M Hold
27,030
– – 0.05% 272
2024
Q1 		$3.57M Hold
27,030
– – 0.07% 254
2023
Q4 		$3.29M Hold
27,030
– – 0.07% 269
2023
Q3 		$3.03M Sell
27,030
-279
-1% -$35.4K 0.07% 271
2023
Q2 		$3.98M Buy
27,309
+12,433
+84% +$1.69M 0.08% 240
2023
Q1 		$1.92M Buy
14,876
+9,114
+158% +$1.14M 0.06% 304
2022
Q4 		$688K Hold
5,762
– – 0.02% 446
2022
Q3 		$602K Buy
+5,762
New +$632K 0.02% 461
2022
Q2 		– Sell
-5,762
Closed -$737K – 658
2022
Q1 		$737K Buy
+5,762
New +$695K 0.02% 490
2021
Q4 		– Sell
-11,143
Closed -$1.58M – 648
2021
Q3 		$1.58M Buy
11,143
+288
+3% +$42.4K 0.05% 373
2021
Q2 		$1.7M Hold
10,855
– – 0.06% 353
2021
Q1 		$1.69M Hold
10,855
– – 0.06% 349
2020
Q4 		$1.62M Buy
10,855
+6,258
+136% +$884K 0.06% 341
2020
Q3 		$607K Sell
4,597
-63,553
-93% -$8.3M 0.03% 426
2020
Q2 		$7.9M Sell
68,150
-4,172
-6% -$481K 0.27% 86
2020
Q1 		$7.1M Buy
72,322
+65,579
+973% +$8.6M 0.33% 70
2019
Q4 		$980K Buy
6,743
+4,596
+214% +$634K 0.04% 374
2019
Q3 		$286K Hold
2,147
– – 0.01% 469
2019
Q2 		$245K Sell
2,147
-571
-21% -$66.9K 0.01% 490
2019
Q1 		$337K Buy
2,718
+1,089
+67% +$124K 0.01% 413
2018
Q4 		$164K Sell
1,629
-8,436
-84% -$949K 0.01% 427
2018
Q3 		$1.28M Buy
10,065
+5,633
+127% +$670K 0.05% 339
2018
Q2 		$479K Hold
4,432
– – 0.02% 460
2018
Q1 		$469K Hold
4,432
– – 0.02% 461
2017
Q4 		$519K Hold
4,432
– – 0.02% 448
2017
Q3 		$503K Hold
4,432
– – 0.03% 404
2017
Q2 		$552K Sell
4,432
-29,995
-87% -$3.56M 0.03% 397
2017
Q1 		$4.08M Buy
+34,427
New +$3.9M 0.19% 138

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Achmea Investment Management's ZBH Position: Q3 2024 in Review

Achmea Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 27,030 shares — an estimated $2.93M sold.

Achmea Investment Management first reported a position in ZBH in Q1 2017 and held it in 28 quarters. The position peaked at $7.9M in Q2 2020. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Achmea Investment Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Achmea Investment Management sold 27,030 Zimmer Biomet shares in Q3 2024, an estimated $2.93M.
  • Achmea Investment Management first reported a position in Zimmer Biomet in Q1 2017 and held it in 28 quarters.
  • Achmea Investment Management's Zimmer Biomet position peaked at $7.9M in Q2 2020.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Achmea Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.